Maria Eva Perez-Lopez
6PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 12, 2025
Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer.Miguel Martín, Ángel L Guerrero-Zotano, María E Pérez-López
|Aug 20, 2023
Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study.Raquel Veiga-Seijo, Sonia Pertega-Diaz, Maria Eva Perez-Lopez
|Apr 13, 2023
Wellbeing and Complementary Therapies in Breast Cancer Peripheral Neuropathy Care: A Scoping Review Focused on Foot Health.Raquel Veiga-Seijo, Maria Eva Perez-Lopez, Uxia Fernandez-Lopez
|Jun 12, 2021
Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer?Silvia Antolín, Lucía García-Caballero, Cristina Reboredo
|May 02, 2021
Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?Silvia Antolín, Lucía García-Caballero, Cristina Reboredo
|Jan 09, 2016
Ki-67 is a prognostic marker for hormone receptor positive tumors.M E Pérez-López, J García-Gómez, M T Alves
Pageof 1
Frequent Collaborators
3 joint publications
Silvia Antolin Novoa
3 joint publications
Lourdes Calvo Martinez
2 joint publications
Lucía García-Caballero
2 joint publications
Tomás García-Caballero
2 joint publications
Cristina Gonzalez-Martin
2 joint publications
Raquel Veiga-Seijo
1 joint publications
Miguel Martín
1 joint publications
Angel L Guerrero-Zotano
1 joint publications
Sonia Pertega-Diaz
1 joint publications
Noelia Martinez Jañez
